Viking Therapeutics (NASDAQ: VKTX)
Viking Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viking Therapeutics Company Info
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
News & Analysis
Why Shares in Viking Therapeutics Surged This Week
The small-cap pharmaceutical company may be the next in line as takeover fever heats up.
Why This Beaten-Down GLP-1 Stock Could Be a Steal
There's more to this company than its performance on the stock market this year suggests.
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
Investors once speculated that Pfizer might consider acquiring Viking.
Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months
Viking's stock took a beating last month, and it has opened up a glorious buying opportunity for investors.
Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
The market may have been too quick to dismiss this biotech's pipeline prospects after a recent trial result.
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Viking aims to enter the billion-dollar weight loss drug market.
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years
Both companies have made significant progress in recent years.
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
Investment bank analysts up and down Wall Street are pounding the table on these stocks.
Valuation
Earnings Transcripts
Viking (VKTX) Q2 2025 Earnings Call Transcript
None
Viking Therapeutics (VKTX) Q2 2022 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2022.
Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript
VKTX earnings call for the period ending March 31, 2022.
Viking Therapeutics (VKTX) Q4 2021 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.